| Literature DB >> 29330509 |
Yunxia Yang1, Tao Han1, Jia Xiao2, Xinyu Li1, Jiteng Wang3.
Abstract
As the cheapest energy source, carbohydrates are used in fish feeds to improve physical quality and reduce catabolism of proteins and lipids. The liver is the primary organ for metabolism and is also an important site of immune regulation. Here, we investigated the effect of different dietary carbohydrate levels on growth and health by evaluating the liver transcriptome of Epinephelus akaara. In this study, E. akaara juveniles were fed diets containing few (0% corn starch), moderate (18% corn starch), and high (30% corn starch) levels of dietary carbohydrate. After an 8-week feeding trial, E. akaara fed 30% dietary carbohydrates exhibited poor growth performance compared with those fed 0% and 18% dietary carbohydrates (P > 0.05). Genes related to the immune system, including IL8, TLR9, CXCR4, CCL4, and NFκB inhibitor alpha, were over-expressed in E. akaara fed the highest level of carbohydrate (30%). This general over-expression could indicate activation of inflammatory processes in the liver. The liver transcriptome data of E. akaara reported here indicate that high carbohydrate level of diet can lead to poor growth and inflammatory immune response in E. akaara.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29330509 PMCID: PMC5766613 DOI: 10.1038/s41598-017-18990-8
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
The expression of growth-related genes in three groups.
| Gene ID | name | C1 | C2 | C3 |
|---|---|---|---|---|
| c56634_g3 | GHR | 11.8233 | 8.4724 | 6.9467 |
| c49944_g2 | IGFBP1 | 1.6992 | 4.3513 | 84.0755 |
| c46871_g1 | IGFBP2A | 12.4657 | 11.8959 | 5.4010 |
| c59085_g2 | IGFBP2B | 102.9990 | 97.3850 | 65.5878 |
| c33486_g1 | IGFBP4 | 0.9967 | 0.7571 | 0.7533 |
| c44323_g3 | IGFBP5 | 16.8376 | 20.6902 | 24.5923 |
| c69225_g1 | IGFBP6 | 0.6224 | 0.3081 | 0.1927 |
| c49986_g1 | IGFBP7 | 2.6987 | 3.8087 | 4.8402 |
| c60956_g7 | IGF1 | 78.6293 | 29.1721 | 17.9944 |
| c59327_g1 | IGF2 | 49.4954 | 6.9903 | 10.1116 |
Sequencing information of the E. akaara liver.
| Samples | C1 | C2 | C3 |
|---|---|---|---|
| Raw Reads Number | 55,912,920 | 63,532,872 | 78,789,902 |
| Clean Reads Number | 48,717,774 | 55,971,730 | 67,230,310 |
| Clean Reads Rate(%) | 87.13 | 88.10 | 85.33 |
| Low-quality Reads Number | 4,827,778 | 5,897,502 | 7,384,488 |
| Low-quality Reads Rate(%) | 8.63 | 9.28 | 9.37 |
| Ns Reads Number | 3,910 | 4,422 | 5,330 |
| Ns Reads Rate(%) | 0.01 | 0.01 | 0.01 |
| Adapter Polluted Reads Number | 2,363,458 | 1,659,218 | 4,169,774 |
| Adapter Polluted Reads Rate(%) | 4.23 | 2.61 | 5.29 |
| Raw Q30 Bases Rate(%) | 89.93 | 90.04 | 88.98 |
| Clean Q30 Bases Rate(%) | 94.84 | 94.86 | 94.67 |
| ORF counts | 27327 | 27851 | 31234 |
| ORF N50 (bp) | 1011 | 1098 | 1074 |
Figure 1GO classification of assembled genes in the E. akaara liver transcriptome.
Figure 2Differentially-expressed gene distribution. For example, 16,998 genes are differentially-expressed in C3 group compared with C1 and C2 groups.
The number of genes whose expression changed in the metabolism pathway between two groups.
| Pathway | c1-c2 up | c1-c2 down | c1-c3 up | c1-c3 down | c3-c2 up | c3-c2 down | |
|---|---|---|---|---|---|---|---|
| Carbohydrate metabolism | |||||||
| 00562 | Inositol phosphate metabolism | 3 | 29 | 45 | 11 | 53 | 6 |
| 00010 | Glycolysis/Gluconeogenesis | 17 | 8 | 52 | 7 | 32 | 8 |
| 00500 | Starch and sucrose metabolism | 10 | 6 | 17 | 19 | 18 | 19 |
| 00520 | Amino sugar and nucleotide sugar metabolism | 15 | 2 | 31 | 4 | 18 | 11 |
| 00620 | Pyruvate metabolism | 25 | 3 | 25 | 3 | 18 | 15 |
| 00051 | Fructose and mannose metabolism | 17 | 3 | 37 | 3 | 21 | 8 |
| 00052 | Galactose metabolism | 11 | 4 | 29 | 7 | 18 | 7 |
| 00640 | Propanoate metabolism | 19 | 0 | 4 | 1 | 3 | 13 |
| 00020 | Citrate cycle(TCA cycle) | 6 | 4 | 16 | 3 | 13 | 2 |
| 00040 | Pentose and glucuronate interconversions | 1 | 1 | 4 | 8 | 7 | 6 |
| 00030 | Pentose phosphate pathway | 8 | 7 | 20 | 7 | 11 | 5 |
| 00053 | Ascorbate and aldarate metabolism | 2 | 2 | 0 | 8 | 4 | 6 |
| 00630 | Glyoxylate and dicarboxylate metabolism | 0 | 2 | 0 | 2 | 2 | 2 |
| 00650 | Butanoate metabolism | 2 | 2 | 4 | 1 | 4 | 2 |
| Energy metabolism | |||||||
| 00190 | Oxidative phosphorylation | 4 | 19 | 25 | 4 | 46 | 0 |
| 00680 | Methane metabolism | 14 | 8 | 22 | 7 | 9 | 5 |
| 00710 | Carbon fixation in photosynthetic organisms | 1 | 5 | 10 | 7 | 8 | 4 |
| 00720 | Carbon fixation pathways in prokaryotes | 2 | 0 | 3 | 0 | 2 | 1 |
| 00195 | Photosynthesis | 0 | 0 | 0 | 0 | 1 | 0 |
| 00920 | Sulfur metabolism | 2 | 0 | 3 | 0 | 2 | 0 |
| 00910 | Nitrogen metabolism | 4 | 1 | 2 | 0 | 2 | 3 |
| Lipid metabolism | |||||||
| 00564 | Glycerophospholipid metabolism | 15 | 23 | 35 | 32 | 33 | 15 |
| 00561 | Glycerolipid metabolism | 13 | 17 | 25 | 26 | 23 | 12 |
| 00600 | Sphingolipid metabolism | 7 | 2 | 13 | 6 | 14 | 2 |
| 00071 | Fatty acid degradation | 1 | 3 | 6 | 8 | 7 | 9 |
| 00590 | Arachidonic acid metabolism | 7 | 6 | 17 | 24 | 17 | 12 |
| 00565 | Ether lipid metabolism | 5 | 4 | 17 | 9 | 16 | 3 |
| 00140 | Steroid hormone biosynthesis | 4 | 11 | 6 | 18 | 5 | 12 |
| 0062 | Fatty acid elongation | 1 | 5 | 12 | 9 | 12 | 5 |
| 00100 | Steroid biosynthesis | 14 | 25 | 16 | 8 | 23 | 4 |
| 01040 | Biosynthesis of unsaturated fatty acids | 1 | 9 | 5 | 10 | 6 | 3 |
| 00591 | Linoleic acid metabolism | 2 | 4 | 8 | 18 | 6 | 7 |
| 00120 | Primary bile acid biosynthesis | 2 | 5 | 3 | 9 | 1 | 5 |
| 00592 | alpha-Linolenic acid metabolism | 0 | 5 | 6 | 9 | 8 | 3 |
| 00061 | Fatty acid biosynthesis | 17 | 0 | 1 | 0 | 0 | 1 |
| 00072 | Synthesis and degradation of ketone bodies | 0 | 1 | 0 | 0 | 3 | 0 |
| 00073 | Cutin, suberine and wax biosynthesis | 5 | 0 | 5 | 0 | 3 | 1 |
| Amino acid metabolism | |||||||
| 00310 | Lysine degradation | 7 | 20 | 19 | 18 | 23 | 11 |
| 00330 | Arginine and proline metabolism | 8 | 6 | 16 | 7 | 15 | 7 |
| 00270 | Cysteine and methionine metabolism | 0 | 7 | 11 | 12 | 10 | 9 |
| 00280 | Valine, leucine and isoleucine degradation | 0 | 1 | 3 | 2 | 7 | 2 |
| 00260 | Glycine, serine and threonine metabolism | 7 | 11 | 14 | 8 | 7 | 4 |
| 00380 | Tryptophan metabolism | 4 | 4 | 6 | 1 | 7 | 2 |
| 00250 | Alanine, aspartate and glutamate metabolism | 0 | 4 | 6 | 2 | 5 | 4 |
| 00340 | Histidine metabolism | 1 | 5 | 3 | 3 | 7 | 2 |
| 00350 | Tyrosine metabolism | 0 | 6 | 7 | 3 | 7 | 0 |
| 00360 | Phenylalanine metabolism | 1 | 5 | 6 | 3 | 7 | 1 |
| 00300 | Lysine biosynthesis | 0 | 1 | 0 | 2 | 0 | 0 |
| 00290 | Valine, leucine and isoleucine biosynthesis | 0 | 0 | 1 | 1 | 0 | 1 |
| Immune system | |||||||
| 04062 | Chemokine signaling pathway | 26 | 13 | 153 | 12 | 144 | 7 |
| 04670 | Leukocyte transendothelial migration | 25 | 16 | 120 | 18 | 110 | 10 |
| 04650 | Natural killer cell mediated cytotoxicity | 25 | 11 | 104 | 9 | 88 | 7 |
| 04660 | T cell receptor signaling pathway | 27 | 17 | 103 | 13 | 88 | 8 |
| 04666 | Fc gamma R-mediated phagocytosis | 18 | 19 | 101 | 14 | 92 | 9 |
| 04662 | B cell receptor signaling pathway | 23 | 7 | 93 | 10 | 77 | 8 |
| 04620 | Toll-like receptor signaling pathway | 17 | 10 | 76 | 8 | 61 | 7 |
| 04640 | Hematopoietic cell lineage | 23 | 4 | 67 | 7 | 48 | 12 |
| 04664 | Fc epsilon RI signaling pathway | 10 | 15 | 63 | 17 | 58 | 6 |
| 04621 | NOD-like receptor signaling pathway | 10 | 4 | 44 | 3 | 39 | 6 |
| 04622 | RIG-I-like receptor signaling pathway | 7 | 7 | 41 | 7 | 32 | 3 |
| 04672 | Intestinal immune network for IgA production | 6 | 0 | 25 | 0 | 18 | 0 |
| 04612 | Antigen processing and presentation | 3 | 3 | 23 | 6 | 22 | 7 |
| 04610 | Complement and coagulation cascades | 6 | 2 | 19 | 10 | 20 | 14 |
| 04623 | Cytosolic DNA-sensing pathway | 4 | 2 | 15 | 2 | 15 | 2 |
| Digestive system | |||||||
| 04972 | Pancreatic secretion | 11 | 25 | 65 | 4 | 63 | 6 |
| 04971 | Gastric acid secretion | 8 | 9 | 50 | 4 | 41 | 3 |
| 04970 | Salivary secretion | 9 | 11 | 42 | 6 | 38 | 5 |
| 04974 | Protein digestion and absorption | 14 | 20 | 95 | 5 | 91 | 5 |
| 04976 | Bile secretion | 9 | 14 | 31 | 16 | 28 | 9 |
| 04973 | Carbohydrate digestion and absorption | 5 | 4 | 25 | 9 | 27 | 7 |
| 04975 | Fat digestion and absorption | 8 | 8 | 8 | 25 | 4 | 16 |
| 04977 | Vitamin digestion and absorption | 3 | 6 | 1 | 25 | 1 | 6 |
| 04978 | Mineral absorption | 6 | 3 | 6 | 5 | 2 | 1 |
The data in table indicate genes involved in carbohydrate metabolism, energy metabolism, lipid metabolism, amino acid metabolism, immune system function, and digestive system function that were up-regulated and downregulated across groups.
Figure 3RT-qPCR confirmation of genes expressed at different carbohydrate level in C1, C2 and C3 groups. Bars represent mean ± standard error of three fish. Aasterisks indicate significant (P < 0.01) differences. The genes chosen for immune system were: APT2: Antigen peptide transporter 2; CCL4: C-C motif chemokine 4; CD3: T-cell surface glycoprotein CD3 delta chain; CIITA: MHC class II transactivator; CXCL10: C-X-C motif chemokine 10; CXCR4: C-X-C chemokine receptor type 4; FOS: Proto-oncogene c-Fos; IKK1: Inhibitor of nuclear factor kappa-B kinase subunit alpha; IL12: Interleukin-12 subunit beta; IL8: Interleukin-8; IRF3: Interferon regulatory factor 3; LCP2: Lymphocyte cytosolic protein 2; NCF1: Neutrophil cytosol factor 1; NFATC: Nuclear factor of activated T-cells; NFKBIA: NF-kappa-B inhibitor alpha; TLR21: Toll-like receptor 2 type-1; TLR9: Toll-like receptor 9; TNF12: Tumor necrosis factor 12; TNFR11: Tumor necrosis factor receptor superfamily member 11.
Primers used for RT-qPCR analyses.
| Gene name | Primer sequence (5′–3′) | Fragment (bp) | Ta (°C) |
|---|---|---|---|
| TAP2 | TGGTTCGCAGCACAGTCA | 262 | 56 |
| GCCTCGTTATACCTCCTCAGT | |||
| Caspase 10 | GCTACGGACAAGACATAC | 257 | 55 |
| GGTGGATGATGAGGAGAA | |||
| CCL4 | TCTCGCTCTGTCTGTGTT | 251 | 56 |
| CGTCCAGGTAGGTGATGA | |||
| CD3 | TTCCAGTACCACAAGACAG | 159 | 53 |
| CCAGGACTCAGAGGTGTA | |||
| CIITA | GTCGGTTAGTCTGCTTGGT | 359 | 55 |
| TGTTCTGTCTGCTTCCTCTC | |||
| CXCL10 | TCTACCAAGCGACCATCT | 290 | 54 |
| GTGTCAGTGCTGTCAGTATA | |||
| CXCR4 | GACTCGGACTCTGTTGAC | 273 | 54 |
| CTGTGTTGGCATCTTCTTG | |||
| FOS | GGAGGTTGAGGTGTAGGT | 216 | 56 |
| GCTAATCTGTTGAAGGAGAAG | |||
| IKK1 | TTAACTCTTCTGGAACCTCTC | 263 | 55 |
| GTGACCTGACCGTATGGA | |||
| IL12 | CCTCACCATCTACATACACAT | 190 | 55 |
| CACCTTGACCTGGAACTG | |||
| IL8 | CCATCTGAGGAGAAGAACTC | 381 | 56 |
| CTGTGTTATTGAGCCTGATTC | |||
| IRF3 | GGAGTCGGCTTGAAGATA | 246 | 55 |
| TCAGTGTGGAAGAGGAAC | |||
| LCP2 | AGTCTGTCTGGCTGTGAT | 151 | 53 |
| TCTCCTCCTTCTTGCTGAT | |||
| NCF1 | TGGTGGTTCTGTCAGTGT | 376 | 58 |
| CCTTGTTGTGGATGCTCTT | |||
| NFATC | GTCTGCTTCATACTCGTCTAT | 136 | 53 |
| TGTCTGCCACTCTGTCAA | |||
| NFKBIA | TGTTGAGGAAGTCTGTGTT | 230 | 56 |
| GCTGAAGGAGGAGGAGTA | |||
| TLR2 | ACTCTGGAGGTGTTGGAT | 280 | 56 |
| CGTTGATGGCTGATTGGA | |||
| TLR9 | CCTACCTTGACATCTCTGAC | 282 | 52 |
| CCGCCTTACTGAAGAACAT | |||
| TNF12 | CTCGCCTCACATCTTCAG | 220 | 52 |
| TCCACAACAACTTCCACAA | |||
| TNFR11 | CAGTGCTGTCAGTCATCA | 127 | 52 |
| TGTATCCTCGTCCTCTTCA | |||
| β actin | CGACCTCACAGACTACCT | 221 | 56 |
| AACGGAACCTCTCATTGC |